ACLU seeks Supreme Court review of Myriad ruling; Dune Medical expands MarginProbe placements;

 @FierceMedDev: Second Sight's Argus II retinal prosthesis will go before an FDA panel tomorrow. More | Follow @FierceMedDev

 @MarkHFierce: Who makes the most among the leaders of the top 20 research institutes? More | Follow @MarkHFierce

 @DamianFierce: With devicemakers big and small angling to cash in on renal denervation, we take a closer look at five hyped-up techs. More | Follow @DamianFierce

> The ACLU is asking the Supreme Court to consider Myriad Genetics ($MYGN) huge legal victory, affirming that isolated genes can be patented. Report

> U-Systems is now actively seeking a partner to help market its new ultrasound cancer test for women with dense breasts, following FDA approval, Bloomberg reports. Story

> Fresh off another round of positive clinical results, Dune Medical secured a placement for its cancer-detecting MarginProbe device at Agaplesion Markus Hospital, in Frankfurt, Germany, the largest hospital in the area. News

> BD Diagnostics ($BDX) has developed a molecular diagnostic for the superbug carbapenem-resistant Enterobacteriaceae. More

> Life Technologies ($LIFE) got 510(k) clearance for its OpTmizer CTS T-cell expansion tissue culture medium, a reagent designed to help grow therapeutic T cells in clinical trials. Item

> Chinese device giant Mindray Medical ($MR) is planning to unveil three new products at next month's China International Medical Equipment Fair: a digital radiography system, a urinalysis diagnostics platform and a hematology analyzer. Announcement

> mBio Diagnostics pulled in $3.9 million to launch its portable, easy-to-use diagnostic platform, testing for infectious diseases like HIV, hepatitis and syphilis. Article

> Amedica got FDA clearance for a second generation of its cervical and lumbar interbody fusion devices, used in spinal surgeries. Release

> Doctors at Glasgow's Beatson West of Scotland Cancer Center have begun using Varian Medical's ($VAR) TrueBeam STx linear accelerator for radiosurgeries, reporting positive patient outcomes. Story

Biotech News

 @FierceBiotech: Check out our report on 10 next-gen biotech drug techs and the pharma's betting on them. More | Follow @FierceBiotech

 @JohnCFierce: Want to reduce the drug spend? Cut the price, by fiat. India designates 348 drugs "essential." More | Follow @JohnCFierce

 @RyanMFierce: My article on genomics outfit Knome, putting genetic tests on computers. More | Follow @RyanMFierce

> Achillion heralds upbeat hepatitis C results as it rushes through Phase II. Story

> Biotech stars make WSJ's list of top startups as healthcare lags. Report

> Science advisors lay out ambitious plan to double FDA approval rates. Article

Pharma News

 @FiercePharma: Deadbeat European states owe pharma between £9.5B and £12B, new report finds. More | Follow @FiercePharma

> Bayer cancer drug races through FDA approval. Item

> Indian ministers put final touches on 348-drug 'essentials' list. Story

> Depomed sues FDA over 'additional hurdles' to orphan exclusivity. Article

Pharma Manufacturing News

 @EricPFierce: Check it out: The 20 top-selling vaccines in H1 2012. Vax market now $27B, total. Special Report | Follow @EricPFierce

> API maker says more clients looking for U.S. manufacturers. Story

> New FDA hand-held scanner sheds light on counterfeits. Article

Vaccines News

 @AlisonBFierce: HIV vaccine trials labor to enroll women.  | Follow @AlisonBFierce

> Medicago, Philip Morris ink China vaccines deal. Article

> Atreca lands $6M for vaccine research. Item

> Johns Hopkins doles out pneumonia prevention grants. Report

> PsiOxus launches human tests of cancer vaccine. Story